Recognizing Dupilumab‐Associated Head and Neck Dermatitis in Skin of Color: A Case Series

Abstract

ABSTRACT Dupilumab‐associated head and neck dermatitis (HND) is a rare and often underrecognized condition, especially in patients with skin of color. It can vary from subtle to severe presentations, with violaceous hues and seborrheic distribution after dupilumab initiation. Early recognition and management are crucial to prevent treatment discontinuation.

Keywords

• antifungal therapy
• dupilumab
• dupixent
• erythema
• skin of color